Monocef-SB 250mg/125mg Injection
Marketer
Aristo Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Monocef-SB 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg) is a dual-action antibiotic used to combat diverse bacterial infections. This medication inhibits bacterial growth, thereby controlling the infection's progression. Administration must be strictly under a doctor's guidance; missed doses should be avoided, and the prescribed course completed regardless of symptom improvement. Premature cessation can compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Severe side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, breathing difficulties) require urgent medical help. Inform your physician about all current medications, and pregnant or breastfeeding individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration are crucial for recovery. Your doctor might order tests to monitor the medication's impact.
Uses of Monocef-SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Monocef-SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Monocef-SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Monocef-SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Monocef-SB 250mg/125mg Injection works:
Ceftriaxone and sulbactam, combined as Monocef-SB 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Monocef-SB 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Monocef-SB (250mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Cefixime/Sulbactam 250mg/125mg injection requires careful consideration during lactation. Breastfeeding should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Monocef-SB 250mg/125mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Monocef-SB 250mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable formulation of Monocef-SB (250mg/125mg) requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alterations for Monocef-SB (250mg/125mg) injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Monocef-SB 250mg/125mg Injection :
Should you forget a scheduled dose of Monocef-SB 250mg/125mg Injection, seek medical advice.
Facts to Know About Monocef-SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |








